|SEQ_NO||1||Date of announcement||2021/03/10||Time of announcement||15:39:26|
|Subject||Announcement of TTY Biopharm's unaudited income information in Feburary 2021|
|Date of events||2021/03/10||To which item it meets||paragraph 53|
|Statement||1.Date of occurrence of the event:2021/03/10
2.Company name:TTY Biopharm Co., Ltd.
3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):Head office
4.Reciprocal shareholding ratios:N/A
5.Cause of occurrence:TTY Biopharm posted a consolidated net sales of $258,866 thousands(expressed in NT dollars; unaudited), a consolidated operating profit of $42,624 thousands, and a consolidated income before tax of $45,143 thousands in Feburary 2021; net income attributed to stockholders of the company was $35,946 thousands; EPS is $0.14.
Year-to-date consolidated net sales was $641,772 thousands (in NT dollars; unaudited), a consolidated operating profit was $154,872 thousands and consolidated income before tax was $164,862 thousands until Feburary 2021; year-to-date net income attributed to stockholders of the company was $131,795 thousands; EPS is $0.53.
7.Any other matters that need to be specified:The numbers above are unaudited. In term of the final net sales and profits, quarterly financial reports audited by independent accountants will prevail.